[Has colectomy for moderate-severe active ulcerative colitis decreased?]

Rev Med Chil. 2023 Mar;151(3):313-320. doi: 10.4067/s0034-98872023000300313.

[Article in Spanish]

Affiliations

¹ Departamento de Cirugía Digestiva, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
² Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
³ Clínica Alemana de Santiago, Facultad Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.

PMID: 38293876
DOI: 10.4067/s0034-98872023000300313

No abstract available

MeSH terms

Colectomy
Colitis, Ulcerative* / drug therapy
Colitis, Ulcerative* / surgery
Gastrointestinal Agents / therapeutic use
Humans
Infliximab / therapeutic use
Treatment Outcome

Substances

Infliximab
Gastrointestinal Agents